Neuroprotection in Stroke-Focus on the Renin-Angiotensin System: A Systematic Review

Sebastian Andone1,2, Zoltan Bajko2,3, Anca Motataianu2,3

  • 1Doctoral School, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Târgu Mures, 540142 Târgu Mures, Romania.

Insights

The renin-angiotensin system offers neuroprotection in stroke, independent of blood pressure. Angiotensin promotes neuroregeneration and neuronal resistance to hypoxia, suggesting new therapeutic avenues for stroke impairment.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Pharmacology

Background:

  • Stroke is a leading cause of adult disability, with hypertension as a major risk factor.
  • The renin-angiotensin system plays a critical role in hypertension and stroke pathophysiology.
  • Understanding the renin-angiotensin system's role in stroke is crucial for developing effective treatments.

Purpose of the Study:

  • To review the current literature on the renin-angiotensin system's role in stroke neuroprotection.
  • To elucidate the mechanisms by which the renin-angiotensin system exerts neuroprotective effects.
  • To explore the potential of targeting the renin-angiotensin system for stroke management.

Main Methods:

  • Literature review of studies investigating the renin-angiotensin system and stroke.
  • Analysis of the effects of angiotensin on AT1, AT2, and Mas receptors.
  • Examination of neuroprotective mechanisms including neuroregeneration, angiogenesis, and hypoxia resistance.

Main Results:

  • The renin-angiotensin system influences stroke through AT1, AT2, and Mas receptors.
  • Angiotensin demonstrates neuroprotective properties in stroke models.
  • These neuroprotective effects appear independent of blood pressure reduction.
  • Observed benefits include enhanced neuroregeneration, angiogenesis, and neuronal hypoxia resistance.

Conclusions:

  • The renin-angiotensin system is a key player in stroke neuroprotection.
  • Its mechanisms involve receptor-mediated pathways promoting tissue repair and resilience.
  • Emerging agonist molecules targeting this system hold promise for future stroke therapies.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
539
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
865
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
953
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
122